Review: The biological basis of antipsychotic response in schizophrenia
- 25 November 2009
- journal article
- review article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (7), 953-964
- https://doi.org/10.1177/0269881109106959
Abstract
Schizophrenia is a severe mental illness affecting approximately 1% of the population worldwide. Antipsychotic drugs are effective in symptom control in up to two-thirds of patients, but in at least one-third of patients the response is poor. The reason for this is not clear, but one possibility is that good and poor responders have different neurochemical pathologies, and may therefore benefit from different treatment approaches. In this selective review we summarise research findings investigating the biological differences between patients with schizophrenia who show a good or a poor response to treatment with antipsychotic drugs.Keywords
This publication has 99 references indexed in Scilit:
- Clozapine interacts with the glycine site of the NMDA receptor: Electrophysiological studies of dopamine neurons in the rat ventral tegmental areaLife Sciences, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophreniaSchizophrenia Research, 2007
- Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical responsePsychiatry Research: Neuroimaging, 2006
- Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatmentSchizophrenia Research, 2005
- Atypical antipsychotics and the relevance of glutamate and serotoninEuropean Neuropsychopharmacology, 2004
- Effects of Clozapine on Plasma Catecholamines and Relation to Treatment Response in Schizophrenia: A Within-Subject Comparison with HaloperidolNeuropsychopharmacology, 1997
- Haloperidol response and plasma catecholamines and their metabolitesSchizophrenia Research, 1993
- Influence of dopamine agonists on plasma and brain levels of homovanillic acidLife Sciences, 1982
- Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in ratsNature, 1980